Ipilimumab

Red

Brand Name(s):Yervoy

Indication:Melanoma – advanced (unresectable or metastatic) in adults and adolescents 12 years of age and older who have received prior therapy.
Renal Cell Carcinoma (RCC)

Rationale:1,2,3

Considered:Jul-11

Review Date:Feb-24

Comments:
Drug Safety Update
Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation
Jan 2019